Skip to content
2000
Volume 15, Issue 1
  • ISSN: 2210-3155
  • E-ISSN: 2210-3163

Abstract

Herbal phytochemicals as secondary metabolites are present in herbal medicines. Herbal medicines can be used to treat a wide range of illnesses and diseases. The Novel herbal drug delivery system approach includes transfersomes, ethosomes, microspheres, phytosomes, liposomes, polymeric nanoparticles, and nanocapsules. The novel herbal drug delivery systems have several benefits over conventional herbal remedies. Herbal medicines are less expensive and have fewer serious side effects than generic medications. The novel herbal drug delivery systems have several benefits over conventional herbal remedies. These include improved solubility and bioavailability, protection from side effects, improved pharmacological action, increased stability, better delivery to tissue macrophages, consistent delivery, and defense against active ingredients' physical and chemical breakdown. There is a need for a novel method of active components of drugs to apply on target organs or sites of the human body to avoid repeated administration of dosage forms and enhance patient adherence. Scientists have tried to focus on advanced mechanisms or processes for delivering herbal components into the human body. Novel Herbal Drug Delivery System helps to boost drug efficacy by lessening side effects and enhancing the blood level of the drug. Novel herbal formulations can reduce recurrent administration of medicines and noncompliance of patients.

Loading

Article metrics loading...

/content/journals/npj/10.2174/0122103155281428240320091344
2025-01-01
2024-11-22
Loading full text...

Full text loading...

References

  1. KunleO.F. EgharevbaH.O. AhmaduP.O. Standardization of herbal medicines –A review.J. Biodivers. Conserv.201243101112
    [Google Scholar]
  2. BarbozaG.E. CanteroJ.J. NúñezC. PacciaroniA. EspinarL.A. Medicinal plants: A general review and a phytochemical and ethnopharmacological screening of the native Argentine Flora. Kurtziana2009347365
    [Google Scholar]
  3. Wachtel-GalorS. BenzieI.F.F. Herbal medicine.In: Biomolecular and Clinical Aspects.2nd edBoca RatonCRC Press/Taylor & Francis2011
    [Google Scholar]
  4. PalS.K. ShuklaY. Herbal medicine: Current status and the future.Asian Pac. J. Cancer Prev.20034428128814728584
    [Google Scholar]
  5. WHO Traditional medicine strategy: 2014-2023. Hong Kong, SAR.ChinaWorld Health Organization2013
    [Google Scholar]
  6. TilburtJ. KaptchukT.J. Herbal medicine research and global health: an ethical analysis.Bull. World Health Organ.200886859459910.2471/BLT.07.04282018797616
    [Google Scholar]
  7. KambojA. Analytical evaluation of herbal drugs. In: Drug discovery research in Pharmacognosy.1st edRijeka, CroatiaTech Publication201210.5772/26109
    [Google Scholar]
  8. BalunasM.J. KinghornA.D. Drug discovery from medicinal plants.Life Sci.200578543144110.1016/j.lfs.2005.09.01216198377
    [Google Scholar]
  9. ButlerM.S. The role of natural product chemistry in drug discovery.J. Nat. Prod.200467122141215310.1021/np040106y15620274
    [Google Scholar]
  10. Guidelines for the regulation of herbal medicines in the South-East Asia Region.New DelhiWorld Health Organization2004
    [Google Scholar]
  11. KrishnaiahY.S.R. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs.J. Bioequivalence Bioavailab.201022283610.4172/jbb.1000027
    [Google Scholar]
  12. TeeranachaideekulV. MüllerR. JunyaprasertV. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)—Effects of formulation parameters on physicochemical stability.Int. J. Pharm.20073401-219820610.1016/j.ijpharm.2007.03.02217482778
    [Google Scholar]
  13. SiddiquiI.A. SannaV. Impact of nanotechnology on the delivery of natural products for cancer prevention and therapy.Mol. Nutr. Food Res.20166061330134110.1002/mnfr.20160003526935239
    [Google Scholar]
  14. AqilF. MunagalaR. JeyabalanJ. VadhanamM.V. Bioavailability of phytochemicals and its enhancement by drug delivery systems.Cancer Lett.2013334113314110.1016/j.canlet.2013.02.03223435377
    [Google Scholar]
  15. AdhamiV.M. MukhtarH. Human cancer chemoprevention: Hurdles and challenges.Top. Curr. Chem.201232920322010.1007/128_2012_34222790416
    [Google Scholar]
  16. NikamP. JainA. SolankiD. AherS. Revolutionizing pharmaceuticals: A deep dive into self-nano emulsifying drug delivery systems.Int. J. Curr. Pharm. Res.20241611910.22159/ijcpr.2024v16i1.4019
    [Google Scholar]
  17. VargasonA.M. AnselmoA.C. MitragotriS. The evolution of commercial drug delivery technologies.Nat. Biomed. Eng.20215995196710.1038/s41551‑021‑00698‑w33795852
    [Google Scholar]
  18. StephenC. Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects.Mater. Adv.202459861016
    [Google Scholar]
  19. MedinaO. ZhuY. KairemoK. Targeted liposomal drug delivery in cancer.Curr. Pharm. Des.200410242981298910.2174/138161204338346715379663
    [Google Scholar]
  20. SinghH. SharmaG. Recent development of novel drug delivery of herbal drugs.RPS Pharmacy and Pharmacology Reports20232rqad02810.1093/rpsppr/rqad028
    [Google Scholar]
  21. JainS. KirarM. BindeliyaM. SenL. SoniM. ShanM. PurohitA. JainP.K. Novel drug delivery systems: An overview.AJDHS202221333910.22270/ajdhs.v2i1.14
    [Google Scholar]
  22. BentS. Herbal medicine in the United States: Review of efficacy, safety, and regulation: Grand rounds at University of California, san francisco medical center.J. Gen. Intern. Med.200823685485910.1007/s11606‑008‑0632‑y18415652
    [Google Scholar]
  23. CalixtoJ.B. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents).Braz. J. Med. Biol. Res.200033217918910.1590/S0100‑879X200000020000410657057
    [Google Scholar]
  24. SaxenaM. SaxenaJ. NemaR. SinghD. GuptaA. Phytochemistry of medicinal plants.J. Pharmacogn. Phytochem.201316168182
    [Google Scholar]
  25. HaslerC.M. BlumbergJ.B. Symposium on phytochemicals: Biochemistry and physiology.J. Nutr.1999129756757
    [Google Scholar]
  26. NdhlalaA.R. StaffordG.I. FinnieJ.F. Van StadenJ. Commercial herbal preparations in KwaZulu-Natal, South Africa: The urban face of traditional medicine.S. Afr. J. Bot.201177483084310.1016/j.sajb.2011.09.002
    [Google Scholar]
  27. CanoJ.H. VolpatoG. Herbal mixtures in the traditional medicine of Eastern Cuba.J. Ethnopharmacol.2004902-329331610.1016/j.jep.2003.10.01215013195
    [Google Scholar]
  28. HarborneJ.B. Phytochemical Methods a Guide to Modern Techniques of Plant Analysis.LondonChapman and Hall Ltd1973
    [Google Scholar]
  29. KauriR. AroraS. Alkaloids-important therapeutic secondary metabolites of plant origin.J. Crit. Rev.20152318
    [Google Scholar]
  30. Güçlü-ÜstündağÖ. MazzaG. Saponins: Properties, applications and processing.Crit. Rev. Food Sci. Nutr.200747323125810.1080/1040839060069819717453922
    [Google Scholar]
  31. ChungK.T. WongT.Y. WeiC.I. HuangY.W. LinY. Tannins and human health: A review.Crit. Rev. Food Sci. Nutr.199838642146410.1080/104086998912742739759559
    [Google Scholar]
  32. KumarS. PandeyA.K. Chemistry and biological activities of flavonoids: An overview.ScientificWorldJournal2013201311610.1155/2013/16275024470791
    [Google Scholar]
  33. PatelD.K. KumarR. LalooD. HemalathaS. Natural medicines from plant source used for therapy of diabetes mellitus: An overview of its pharmacological aspects.Asian Pac. J. Trop. Dis.20122323925010.1016/S2222‑1808(12)60054‑1
    [Google Scholar]
  34. WassieS.M. AragieL.L. TayeB.W. MekonnenL.B. Knowledge, attitude, and utilization of traditional medicine among the communities of Merawi town, Northwest Ethiopia: A cross-sectional study.Evid. Based Complement. Alternat. Med.201520151710.1155/2015/13807326508974
    [Google Scholar]
  35. MhameP. the role of traditional knowledge (TK) in the National Economy: the importance and scope of TK, particularly traditional medicine in Tanzania In: UNCTAD Expert Meeting on Systems and National Experiences for Protecting Traditional Knowledge, Innovations and Practices; Geneva, 2000.
    [Google Scholar]
  36. WHO Traditional Medicine Strategy 2002-2005; Geneva2002
    [Google Scholar]
  37. MaroyiA. Traditional use of medicinal plants in south-central Zimbabwe: Review and perspectives.J. Ethnobiol. Ethnomed.2013913110.1186/1746‑4269‑9‑3123642285
    [Google Scholar]
  38. PandeyM.M. RastogiS. RawatA.K.S. Indian traditional ayurvedic system of medicine and nutritional supplementation.Evid. Based Complement. Alternat. Med.2013201311210.1155/2013/37632723864888
    [Google Scholar]
  39. QaziM.A. MolviK. Herbal medicine: A comprehensive review.J. Pharm. Res.20168215
    [Google Scholar]
  40. BarnesP.M. BloomB. Complementary and alternative medicine use among adults and children: United States, 2007.Natl. Health Stat. Report.20071012123
    [Google Scholar]
  41. BorokiniT.I. OmotayoF.O. Phytochemical and ethnobotanical study of some selected medicinal plants from Nigeria.J. Med. Plants Res.2012671106111810.5897/JMPR09.430
    [Google Scholar]
  42. KoehnF.E. CarterG.T. The evolving role of natural products in drug discovery.Nat. Rev. Drug Discov.20054320622010.1038/nrd165715729362
    [Google Scholar]
  43. WilliamsonE. Synergy and other interactions in phytomedicines.Phytomedicine20018540140910.1078/0944‑7113‑0006011695885
    [Google Scholar]
  44. RaskinI. RipollC. Can an apple a day keep the doctor away?Curr. Pharm. Des.200410273419342910.2174/138161204338307015544525
    [Google Scholar]
  45. Gómez CastellanosJ.R. PrietoJ.M. HeinrichM. Red Lapacho (Tabebuia impetiginosa)—A global ethnopharmacological commodity?J. Ethnopharmacol.2009121111310.1016/j.jep.2008.10.00418992801
    [Google Scholar]
  46. CravottoG. BoffaL. GenziniL. GarellaD. Phytotherapeutics: An evaluation of the potential of 1000 plants.J. Clin. Pharm. Ther.2010351114810.1111/j.1365‑2710.2009.01096.x20175810
    [Google Scholar]
  47. SchmidtB. RibnickyD.M. PoulevA. LogendraS. CefaluW.T. RaskinI. A natural history of botanical therapeutics.Metabolism2008577Suppl. 1S3S910.1016/j.metabol.2008.03.00118555851
    [Google Scholar]
  48. LilaM.A. RaskinI. Health-related Interactions of phytochemicals.J. Food Sci.2005701R20R2710.1111/j.1365‑2621.2005.tb09054.x
    [Google Scholar]
  49. CapassoR. AvielloG. BorrelliF. RomanoB. FerroM. CastaldoL. MontanaroV. AltieriV. IzzoA.A. Inhibitory effect of standardized Cannabis sativa extract and its ingredient cannabidiol on rat and human bladder contractility.Urology20117741006.e91006.e1510.1016/j.urology.2010.12.00621310467
    [Google Scholar]
  50. De SmetP.A.G.M. Herbal remedies.N. Engl. J. Med.2002347252046205610.1056/NEJMra02039812490687
    [Google Scholar]
  51. NortierJ.L. MartinezM.C.M. SchmeiserH.H. ArltV.M. BielerC.A. PeteinM. DepierreuxM.F. De PauwL. AbramowiczD. VereerstraetenP. VanherweghemJ.L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).N. Engl. J. Med.2000342231686169210.1056/NEJM20000608342230110841870
    [Google Scholar]
  52. StickelF. PatsenkerE. SchuppanD. Herbal hepatotoxicity.J. Hepatol.200543590191010.1016/j.jhep.2005.08.00216171893
    [Google Scholar]
  53. ShekelleP.G. HardyM.L. MortonS.C. MaglioneM. MojicaW.A. SuttorpM.J. RhodesS.L. JungvigL. GagnéJ. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis.JAMA2003289121537154510.1001/jama.289.12.153712672771
    [Google Scholar]
  54. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk. Final rule.Fed. Regist.200469286787685414968803
    [Google Scholar]
  55. HoffmanB.B. TaylorP. Neurotransmission.In: Goodman and Gilman’s The Pharmacological Basis of Therapeutics. 10. HardmanJ.G. LimbirdL.E. New York, NYMcGrawHill2001115153
    [Google Scholar]
  56. HabeckM. BenowitzN.L. JacobP.III Diabetes treatments get sweet help from nature.Nat. Med.2003910122810.1038/nm1003‑1228a14520349
    [Google Scholar]
  57. MorrisC.A. AvornJ. Internet marketing of herbal products.JAMA2003290111505150910.1001/jama.290.11.150513129992
    [Google Scholar]
  58. LarsenH.O. OlsenC.S. Unsustainable collection and unfair trade? Uncovering and assessing assumptions regarding Central Himalayan medicinal plant conservation.Biodivers. Conserv.20071661679169710.1007/s10531‑006‑9039‑4
    [Google Scholar]
  59. BakerD.D. ChuM. OzaU. RajgarhiaV. The value of natural products to future pharmaceutical discovery.Nat. Prod. Rep.20072461225124410.1039/b602241n18033577
    [Google Scholar]
  60. ChanK. ShawD. SimmondsM.S.J. LeonC.J. XuQ. LuA. SutherlandI. IgnatovaS. ZhuY.P. VerpoorteR. WilliamsonE.M. DuezP. Good practice in reviewing and publishing studies on herbal medicine, with special emphasis on traditional Chinese medicine and Chinese materia medica.J. Ethnopharmacol.2012140346947510.1016/j.jep.2012.01.03822330011
    [Google Scholar]
  61. MuchugiA. MuluviG.M. KindtR. KaduC.A.C. SimonsA.J. JamnadassR.H. Genetic structuring of important medicinal species of genus Warburgia as revealed by AFLP analysis.Tree Genet. Genomes20084478779510.1007/s11295‑008‑0151‑3
    [Google Scholar]
  62. MakungaN.P. PhilanderL.E. SmithM. Current perspectives on an emerging formal natural products sector in South Africa.J. Ethnopharmacol.2008119336537510.1016/j.jep.2008.07.02018703128
    [Google Scholar]
  63. SemwalD.P. SaradhiP.P. NautiyalB.P. BhattA.B. Current status, distribution and conservation of rare and endangered medicinal plants of Kedarnath Wildlife Sanctuary, Central Himalayas, India.Curr Sci India.20079217331738
    [Google Scholar]
  64. MaJ. RongK. ChengK. Research and practice on biodiversity in situ conservation in China: Progress and prospect.Shengwu Duoyangxing201220551558
    [Google Scholar]
  65. MadniA. RahimM.A. MahmoodM.A. JabarA. RehmanM. ShahH. KhanA. TahirN. ShahA. Enhancement of dissolution and skin permeability of pentazocine by proniosomes and niosomal gel.AAPS PharmSciTech20181941544155310.1208/s12249‑018‑0967‑629470828
    [Google Scholar]
  66. AhmadM.Z. MohammedA.A. Mokhtar IbrahimM. Technology overview and drug delivery application of proniosome.Pharm. Dev. Technol.201722330231110.3109/10837450.2015.113534426794727
    [Google Scholar]
  67. PrasadN.S. Augmentation of dissolution profile of poorly soluble Olmesartan medoximil formulating into pronisomes.European JBPS201632122128
    [Google Scholar]
  68. BonifácioB.V. SilvaP.B. RamosM.A. NegriK.M.S. BauabT.M. ChorilliM. Nanotechnology-based drug delivery systems and herbal medicines: A review.Int. J. Nanomedicine2014911524363556
    [Google Scholar]
  69. SharmaM. Applications of nanotechnology based dosage forms for delivery of herbal drugs. Research and Reviews.J. Pharm. Nanotechnol.2014212330
    [Google Scholar]
  70. LiD.C. ZhongX.K. ZengZ.P. JiangJ.G. LiL. ZhaoM.M. YangX.Q. ChenJ. ZhangB.S. ZhaoQ.Z. XieM.Y. XiongH. DengZ.Y. ZhangX.M. XuS.Y. GaoY.X. Application of targeted drug delivery system in Chinese medicine.J. Control. Release2009138210311210.1016/j.jconrel.2009.05.00819433120
    [Google Scholar]
  71. HongW. ChenD.W. ZhaoX.L. QiaoM.X. HuH.Y. Preparation and study in vitro of long-circulating nanoliposomes of curcumin.Zhongguo Zhongyao Zazhi200833888989218619344
    [Google Scholar]
  72. WenZ. LiuB. ZhengZ. YouX. PuY. LiQ. Preparation of liposomes entrapping essential oil from Atractylodes macrocephala Koidz by modified RESS technique.Chem. Eng. Res. Des.20108881102110710.1016/j.cherd.2010.01.020
    [Google Scholar]
  73. SunP. DenS.H. YuW.P. Evaluation of garlicin liposomes.J Shan Univ TCM2007313739
    [Google Scholar]
  74. GuptaV.K. KararP.K. RameshS. MisraS.P. GuptaA. Nanoparticle formulation for hydrophilic and hydrophobic drugs.Int J Res Pharm Sci20101163169
    [Google Scholar]
  75. LiraM.C.B. FerrazM.S. SilvaD.G.V.C. CortesM.E. TeixeiraK.I. CaetanoN.P. SinisterraR.D. PonchelG. Santos-MagalhãesN.S. Inclusion complex of usnic acid with β-cyclodextrin: Characterization and nanoencapsulation into liposomes.J. Incl. Phenom. Macrocycl. Chem.2009643-421522410.1007/s10847‑009‑9554‑5
    [Google Scholar]
  76. DwivediC. VermaS. Review on preparation and characterization of liposomes with application.J. Scientific & Innov. Res.20132486508
    [Google Scholar]
  77. AsijiaR. Development of proniosomes gel as a drug carrier for transdermal delivery of acyclovir.J. Drug Deliv. Ther.20142184151
    [Google Scholar]
  78. JainN. GuptaB.P. ThakurN. JainR. BanweerJ. JainD. JainS. Phytosome: A novel drug delivery system for herbal medicine.Int. J. Pharm. Sci. Drug Res.201024224228
    [Google Scholar]
  79. YanyuX. YunmeiS. ZhipengC. QinengP. The preparation of silybin–phospholipid complex and the study on its pharmacokinetics in rats.Int. J. Pharm.20063071778210.1016/j.ijpharm.2005.10.00116300915
    [Google Scholar]
  80. MaitiK. MukherjeeK. GantaitA. BishnuP.S. MukherjeeP.K. Enhanced therapeutic potential of naringenin-phospholipid complex in rats.J. Pharm. Pharmacol.2006581227123310.1211/jpp.58.9.000916945181
    [Google Scholar]
  81. MaitiK. MukherjeeK. GantaitA. AhamedH.N. SahaB.P. MukherjeeP.K. Enhanced therapeutic benefit of quercetin – Phospholipid complex in carbon tetrachloride–induced acute liver injury in rats: A comparative study.Iran J Pharmacol Ther200548490
    [Google Scholar]
  82. MaitiK. MukherjeeK. GantaitA. SahaB.P. MukherjeeP.K. Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats.Int. J. Pharm.20073301-215516310.1016/j.ijpharm.2006.09.02517112692
    [Google Scholar]
  83. BhattacharyaS. Phytosomes: Emerging strategy in delivery of herbal drugs and nutraceuticals.Pharm. Times200941912
    [Google Scholar]
  84. PandaV.S. NaikS.R. Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: A biochemical and histoarchitectural evaluation.Exp. Toxicol. Pathol.2008604-539740410.1016/j.etp.2008.03.01018513933
    [Google Scholar]
  85. KareparambanJ.A. NikamP.H. JadhavP.A. KadamV.J. Phytosome: A novel revolution in herbal drugs.Int. J. Res. Pharm. Chem.201222299310
    [Google Scholar]
  86. DeshpandeP.K. PathakA.P. GothalwalR. Phytosomes: A novel drug delivery system for phytoconstituents.J. New Biol. Rep.201433212220
    [Google Scholar]
  87. MamillapalliV. AtmakuriA.M. KhantamneniP. Nanoparticles for herbal extracts.Asian J. Pharm.20161025460
    [Google Scholar]
  88. AbiramiA. HalithS.M. PillaiK.K. AnbalaganC. Herbal nanoparticle for anticancer potential- A review.World J. Pharm. Pharm. Sci.20143821232132
    [Google Scholar]
  89. ShimadaS. Composition comprising nanoparticle ginkgo biloba extract with the effect of brain function activation. U.S. Patent 20080254126A1,2008
    [Google Scholar]
  90. MinK.H. ParkK. KimY.S. BaeS.M. LeeS. JoH.G. ParkR.W. KimI.S. JeongS.Y. KimK. KwonI.C. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.J. Control. Release2008127320821810.1016/j.jconrel.2008.01.01318336946
    [Google Scholar]
  91. MukerjeeA. VishwanathaJ.K. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.Anticancer Res.200929103867387519846921
    [Google Scholar]
  92. Feng-LinY. Tzu-HuiW. Liang-TzungL. Thau-MingC. Chun-ChingL. Naringenin-loaded nanoparticles improve the physicochemical properties and the hepatoprotective effects of naringenin in orally-administered rats with CCl(4)-induced acute liver failure.Pharm. Res.200926489390210.1007/s11095‑008‑9791‑019034626
    [Google Scholar]
  93. LertsutthiwongP. NoomunK. JongaroonngamsangN. RojsitthisakP. NimmannitU. Preparation of alginate nanocapsules containing turmeric oil.Carbohydr. Polym.200874220921410.1016/j.carbpol.2008.02.009
    [Google Scholar]
  94. LiuM. LiH. LuoG. LiuQ. WangY. Pharmacokinetics and biodistribution of surface modification polymeric nanoparticles.Arch. Pharm. Res.200831454755410.1007/s12272‑001‑1191‑818449515
    [Google Scholar]
  95. Tzu-HuiW. Feng-LinY. Liang-TzungL. Tong-RongT. Chun-ChingL. Thau-MingC. Preparation, physicochemical characterization, and antioxidant effects of quercetin nanoparticles.Int. J. Pharm.20083461–216016817689897
    [Google Scholar]
  96. HouJ. ZhouS.W. ACTA Academiae medicinae militaris tertiae20083010431048
    [Google Scholar]
  97. LiY.C. DongL. JiaK. ChangX.M. XueH. Xi’an Jiaotong University.Med. Sci.200728517520
    [Google Scholar]
  98. YoufangC. XianfuL. HyunjinP. RichardG. Study of artemisinin nanocapsules as anticancer drug delivery systems.Nanomedicine 20095331632219523432
    [Google Scholar]
  99. AlsarraA. Proniosomes as a drug carrier for transdermal delivery of ketorolac.Eur. J. Pharm. Biopharm.20041051615760729
    [Google Scholar]
  100. ŞanlıO. Karacaİ. IşıklanN. Preparation, characterization, and salicylic acid release behavior of chitosan/poly(vinyl alcohol) blend microspheres.J. Appl. Polym. Sci.200911162731274010.1002/app.29319
    [Google Scholar]
  101. XiaoL. ZhangY.H. XuJ.C. JinX.H. Preparation of floating rutin-alginate-chitosan microcapsule.Chin. Tradit. Herbal Drugs20082209212
    [Google Scholar]
  102. YouJ. CuiF. HanX. WangY. YangL. YuY. LiQ. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion–solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.Colloids Surf. B Biointerfaces2006481354110.1016/j.colsurfb.2005.12.01116480856
    [Google Scholar]
  103. MachidaY. OnishiH. KuritaA. HataH. MorikawaA. MachidaY. Pharmacokinetics of prolonged-release CPT-11-loaded microspheres in rats.J. Control. Release2000662-315917510.1016/S0168‑3659(99)00267‑910742577
    [Google Scholar]
  104. ChaoP. DeshmukhM. KutscherH.L. GaoD. RajanS.S. HuP. LaskinD.L. SteinS. SinkoP.J. Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.Anticancer Drugs2010211657610.1097/CAD.0b013e328332a32219966540
    [Google Scholar]
  105. YadavM. BhatiaV.J. DoshiG. ShastriK. Novel techniques in herbal drug delivery systems.Int. J. Pharm. Sci. Rev. Res.20142828389
    [Google Scholar]
  106. FatimaG.X. RahulR.S. ReshmaI. SandeepT. ShanmuganathanS. ChamundeeswariD. Herbal ethosomes - A novel approach in herbal drug technology.American J. Ethonomedicine.201414226230
    [Google Scholar]
  107. AjazuddinS. SarafS. Applications of novel drug delivery system for herbal formulations.Fitoterapia201081768068910.1016/j.fitote.2010.05.00120471457
    [Google Scholar]
  108. SachanR. ParasharT. A drug carrier transferosomes: A novel tool for transdermal drug delivery system.IJRDPL201322309316
    [Google Scholar]
  109. LongX.Y. LuoJ.B. LiL.R. LinD. RongH.S. HuangW.M. Preparation and in vitro evaluations of topically applied capsaicin transfersomes.Zhongguo Zhongyao Zazhi2006311298198417048643
    [Google Scholar]
  110. SinghH.P. UtrejaP. TiwaryA.K. JainS. Elastic liposomal formulation for sustained delivery of colchicine: in vitro characterization and in vivo evaluation of anti-gout activity.AAPS J.2009111546410.1208/s12248‑008‑9078‑819191031
    [Google Scholar]
  111. ZhaowuZ. XiaoliW. YangdeZ. NianfengL. Preparation of matrine ethosome, its percutaneous permeation in vitro and anti-inflammatory activity in vivo in rats.J. Liposome Res.200919215516210.1080/0898210090272238119241204
    [Google Scholar]
  112. PaolinoD. LucaniaG. MardenteD. AlhaiqueF. FrestaM. Ethosomes for skin delivery of ammonium glycyrrhizinate: In vitro percutaneous permeation through human skin and in vivo anti inflammatory activity.J. Control. Release20051061-299110
    [Google Scholar]
  113. MaB. DuanX. WangZ. Clinical and experimental study on Shuanghua aerosol in treating infantile upper respiratory tract infection.Chung Kuo Chung Hsi I Chieh Ho Tsa Chih200020965365511789167
    [Google Scholar]
  114. JadhavV. BhogaleV. Novel drug delivery system in herbal.Int. J. Pharm. Wave.20151285103
    [Google Scholar]
  115. PascoaH. DinizD.G.A. FlorentinoI.F. CostaE.A. BaraM.T.F. Microemulsion based on Pterodon emarginatus oil and its anti-inflammatory potential.Braz. J. Pharm. Sci.201551111712510.1590/S1984‑82502015000100013
    [Google Scholar]
  116. LuM.F. ChengY.Q. LiL.J. WuJ.J. Progress of study on passive targeting of drug delivery system.Mater Rev200519108110
    [Google Scholar]
  117. ZhouX. LiL.Y. GuoZ.J. Application of targeted drug delivery system in chinese medicine.Linchuang Zhongliuxue Zazhi20049229234
    [Google Scholar]
  118. MeiZ. ChenH. WengT. YangY. YangX. Solid lipid nanoparticle and microemulsion for topical delivery of triptolide.Eur. J. Pharm. Biopharm.200356218919610.1016/S0939‑6411(03)00067‑512957632
    [Google Scholar]
  119. LiL. WangD.K. LiL.S. JiaJ. ChangD. AiL. Preparation of docetaxel submicron emulsion formation for intravenous administration.J. Shenyang Pharm. Univ.200712736739
    [Google Scholar]
  120. SunH.W. OuyangW.Q. Preparation, quality and safety evaluation of berbarine nano emulsion for oral application.J. Shanghai Jiaotong Univ.200716065
    [Google Scholar]
  121. TangriP. KhuranaS. Niosomes: Formulation and evaluation.Int J Biopharm201124753
    [Google Scholar]
  122. GuptaS. SinghR.P. LokwaniP. YadavS. GuptaS.K. Vesicular system as targeted drug delivery system: An overview.Int J Pharm Technol201139871021
    [Google Scholar]
  123. ShuklaN.D. TiwariM. Proniosomal drug delivery systems – Clinical applications.Int. J. Res. Pharm. Biomed. Sci.20112880887
    [Google Scholar]
  124. GoyalC. AhujaM. SharmaS.K. Preparation and evaluation of anti-inflammatory activity of gugulipid-loaded proniosomal gel.Acta Pol. Pharm.201168114715021485714
    [Google Scholar]
  125. RajaK. UkkenJ.P. AthulP.V. TamizharasiS. SivakumarT. Formulation and evaluation of maltodextrin based proniosomal drug delivery system containing anti-diabetic (glipizide) drug.Int. J. Pharm. Tech. Res.20113471477
    [Google Scholar]
/content/journals/npj/10.2174/0122103155281428240320091344
Loading
/content/journals/npj/10.2174/0122103155281428240320091344
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test